JP2010530356A5 - - Google Patents

Download PDF

Info

Publication number
JP2010530356A5
JP2010530356A5 JP2010500974A JP2010500974A JP2010530356A5 JP 2010530356 A5 JP2010530356 A5 JP 2010530356A5 JP 2010500974 A JP2010500974 A JP 2010500974A JP 2010500974 A JP2010500974 A JP 2010500974A JP 2010530356 A5 JP2010530356 A5 JP 2010530356A5
Authority
JP
Japan
Prior art keywords
composition
env
sequence signature
hiv
infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010500974A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010530356A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/003965 external-priority patent/WO2008118470A2/en
Publication of JP2010530356A publication Critical patent/JP2010530356A/ja
Publication of JP2010530356A5 publication Critical patent/JP2010530356A5/ja
Pending legal-status Critical Current

Links

JP2010500974A 2007-03-27 2008-03-27 急性伝染hivエンベロープ・サイン Pending JP2010530356A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90725907P 2007-03-27 2007-03-27
PCT/US2008/003965 WO2008118470A2 (en) 2007-03-27 2008-03-27 Acute transmitted hiv envelope signatures

Publications (2)

Publication Number Publication Date
JP2010530356A JP2010530356A (ja) 2010-09-09
JP2010530356A5 true JP2010530356A5 (cg-RX-API-DMAC7.html) 2011-05-12

Family

ID=39789201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010500974A Pending JP2010530356A (ja) 2007-03-27 2008-03-27 急性伝染hivエンベロープ・サイン

Country Status (7)

Country Link
US (1) US20100104596A1 (cg-RX-API-DMAC7.html)
EP (1) EP2129395A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010530356A (cg-RX-API-DMAC7.html)
CN (1) CN101969997A (cg-RX-API-DMAC7.html)
AU (1) AU2008231306A1 (cg-RX-API-DMAC7.html)
CA (1) CA2682206A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008118470A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2358757T3 (pl) 2008-11-18 2019-02-28 Beth Israel Deaconess Medical Center Szczepionki antywirusowe o ulepszonej immunogenności komórkowej
US20130177583A1 (en) * 2010-03-03 2013-07-11 Duke University Molecular clone of hiv-1
WO2011126576A2 (en) * 2010-04-09 2011-10-13 Duke University Genetic signatures in the envelope glycoprotein of hiv-1
EP3526236B1 (en) 2016-10-17 2025-12-10 Beth Israel Deaconess Medical Center, Inc. Signature-based human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585979B1 (en) * 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US20030215793A1 (en) * 2002-01-17 2003-11-20 Hahn Beatrice H. Complete genome sequence of a simian immunodeficiency virus from a wild chimpanzee
RU2237065C2 (ru) * 2002-10-03 2004-09-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Иммуногенная библиотека химерных пептидов, мимикрирующая генетическое многообразие гипервариабельного района v3 белка оболочки gp120 вируса иммунодефицита человека
CA2539325C (en) * 2003-09-17 2016-03-22 Duke University Consensus/ancestral immunogens
DE10343901A1 (de) * 2003-09-19 2005-04-14 Basf Ag Amidgruppenhaltige Ethylenterpolymere und ihre Verwendung
WO2005035555A1 (en) * 2003-10-10 2005-04-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hiv/siv env chimeras that promote trimerization and maintain targets of neutralizing antibodies

Similar Documents

Publication Publication Date Title
Agrawal Heterologous immunity: role in natural and vaccine-induced resistance to infections
Plotkin Complex correlates of protection after vaccination
Zhang et al. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection
Laguette et al. Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins
Jary et al. Kaposi’s sarcoma-associated herpesvirus, the etiological agent of all epidemiological forms of Kaposi’s sarcoma
De Souza et al. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope
Richardson et al. Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates
US12472244B2 (en) Immunogenic compositions and uses thereof
EP2983686A4 (en) STABILIZED HUMANE IMMUNODEFICIENCY VIRUS COVENANT TRIMER VACCINES AND METHOD FOR USE THEREOF
NZ602504A (en) Antiviral vaccines with improved cellular immunogenicity
MX2012002531A (es) Generacion de una respuesta amplia de celulas t en humanos contra el virus de inmunodeficiencia humana (vih).
De Goede et al. Understanding HIV infection for the design of a therapeutic vaccine. Part I: Epidemiology and pathogenesis of HIV infection
JP2015500854A5 (cg-RX-API-DMAC7.html)
CN117083289A (zh) 嵌合腺病毒载体
Xie et al. Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice
HRP20171697T1 (hr) Varijanta hiv gp-120
Kerina et al. HIV diversity and classification, role in transmission
WO2008091398A3 (en) Jc virus vaccine
EP2567967A3 (en) Method of using adenoviral vectors to induce an immune response
RU2012130551A (ru) Штамм вируса гриппа а/17/виктория/2011/89 (h3n2) для производства живой гриппозной интраназальной вакцины для взрослых и для детей
Frey HIV vaccines
CN101969997A (zh) 急性传播的hiv包膜标记物
JP2007515386A5 (cg-RX-API-DMAC7.html)
HK1203358A1 (en) Vaccination with interleukin-4 antagonists
Ranga et al. HIV/AIDS research in India: past, present and future